US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist

0.007400
+0.000300+4.23%

15min DelayTrading Jul 11 10:57 ET

230.22KMarket Cap0.01P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

(FY)Aug 31, 2022

(Q4)Aug 31, 2022

(Q3)May 31, 2022

Total revenue

40.64K

89.44K

1,269.13%410.17K

233.80%100K

310.17K

29.96K

Operating revenue

--40.64K

--89.44K

1,269.13%410.17K

233.80%100K

--310.17K

--0

--29.96K

--0

Cost of revenue

6.22K

Gross profit

34.42K

Operating expense

-3.67%240.85K

-24.64%261.34K

-55.04%1.34M

-48.56%261.5K

-23.90%483.25K

-65.76%250.01K

-68.77%346.79K

14.76%2.98M

-14.76%508.31K

-6.10%635.01K

Selling and administrative expenses

-43.77%133.65K

-47.55%148.92K

-49.46%909.98K

-51.19%168.26K

-42.96%220.13K

-40.53%237.68K

-57.65%283.9K

117.30%1.8M

175.06%344.71K

207.75%385.95K

-Selling and marketing expense

----

-92.35%1.22K

----

-21.08%15.98K

----

-General and administrative expense

-43.77%133.65K

-47.55%148.92K

-49.08%908.76K

-49.19%167.04K

-42.96%220.13K

-40.53%237.68K

-57.65%283.9K

120.77%1.78M

212.85%328.74K

207.75%385.95K

Research and development costs

769.56%107.2K

78.76%112.42K

-63.53%431.57K

-43.01%93.24K

5.64%263.12K

-96.27%12.33K

-85.71%62.89K

-33.21%1.18M

-65.27%163.6K

-54.79%249.06K

Operating profit

17.43%-206.43K

50.43%-171.9K

68.47%-931.38K

66.24%-161.5K

72.74%-173.08K

65.76%-250.01K

68.77%-346.79K

-13.61%-2.95M

19.78%-478.35K

6.10%-635.01K

Net non-operating interest income expense

-77.70%4.68K

39.12%-6.62K

7.78%-1.17K

103.55%27.33K

-139.43%-18.39K

104.13%20.99K

94.88%-10.88K

97.93%-1.27K

-219.44%-769.2K

107.20%46.65K

Non-operating interest expense

----

-39.12%6.62K

-7.78%1.17K

----

-94.88%10.88K

-46.76%1.27K

----

Total other finance cost

77.70%-4.68K

----

139.43%18.39K

-104.13%-20.99K

----

---46.65K

Other net income (expense)

94.84%-123.71K

-93.28%-2.78M

-382.38K

-2.4M

-169.69%-1.44M

Gain on sale of security

94.84%-123.71K

----

-5,848.90%-2.72M

---327.57K

----

---2.4M

----

-126.31%-45.77K

----

Special income (charges)

----

--0

----

---669.13K

----

-Gain on sale of property,plant,equipment

----

--0

----

---669.13K

----

Other non- operating income (expenses)

----

92.41%-54.81K

----

-2.17%-722.24K

----

Income before tax

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

80.76%-516.56K

67.46%-191.47K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-294.14%-2.68M

55.55%-588.36K

Income tax

Net income

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

48.51%-681.65K

Net income continuous Operations

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

48.51%-681.65K

Minority interest income

Net income attributable to the parent company

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

48.51%-681.65K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

48.51%-681.65K

Basic earnings per share

99.25%-0.01

99.70%-0.001

88.30%-0.42

97.30%-0.0254

96.37%-0.02

-31.68%-1.33

72.50%-0.33

-49.58%-3.59

-394.74%-0.94

52.97%-0.5502

Diluted earnings per share

99.25%-0.01

99.70%-0.001

88.30%-0.42

97.30%-0.0254

96.37%-0.02

-31.68%-1.33

72.50%-0.33

-49.58%-3.59

-394.74%-0.94

52.97%-0.5502

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022	(FY)Aug 31, 2022	(Q4)Aug 31, 2022	(Q3)May 31, 2022
Total revenue	40.64K	89.44K	1,269.13%410.17K	233.80%100K	310.17K	0	0	29.96K	29.96K	0
Operating revenue	--40.64K	--89.44K	1,269.13%410.17K	233.80%100K	--310.17K	--0	--0	--29.96K	--29.96K	--0
Cost of revenue	6.22K					0
Gross profit	34.42K					0
Operating expense	-3.67%240.85K	-24.64%261.34K	-55.04%1.34M	-48.56%261.5K	-23.90%483.25K	-65.76%250.01K	-68.77%346.79K	14.76%2.98M	-14.76%508.31K	-6.10%635.01K
Selling and administrative expenses	-43.77%133.65K	-47.55%148.92K	-49.46%909.98K	-51.19%168.26K	-42.96%220.13K	-40.53%237.68K	-57.65%283.9K	117.30%1.8M	175.06%344.71K	207.75%385.95K
-Selling and marketing expense	----	----	-92.35%1.22K	----	----	----	----	-21.08%15.98K	----	----
-General and administrative expense	-43.77%133.65K	-47.55%148.92K	-49.08%908.76K	-49.19%167.04K	-42.96%220.13K	-40.53%237.68K	-57.65%283.9K	120.77%1.78M	212.85%328.74K	207.75%385.95K
Research and development costs	769.56%107.2K	78.76%112.42K	-63.53%431.57K	-43.01%93.24K	5.64%263.12K	-96.27%12.33K	-85.71%62.89K	-33.21%1.18M	-65.27%163.6K	-54.79%249.06K
Operating profit	17.43%-206.43K	50.43%-171.9K	68.47%-931.38K	66.24%-161.5K	72.74%-173.08K	65.76%-250.01K	68.77%-346.79K	-13.61%-2.95M	19.78%-478.35K	6.10%-635.01K
Net non-operating interest income expense	-77.70%4.68K	39.12%-6.62K	7.78%-1.17K	103.55%27.33K	-139.43%-18.39K	104.13%20.99K	94.88%-10.88K	97.93%-1.27K	-219.44%-769.2K	107.20%46.65K
Non-operating interest expense	----	-39.12%6.62K	-7.78%1.17K	----	----	----	-94.88%10.88K	-46.76%1.27K	----	----
Total other finance cost	77.70%-4.68K	----	----	----	139.43%18.39K	-104.13%-20.99K	----	----	----	---46.65K
Other net income (expense)	94.84%-123.71K		-93.28%-2.78M	-382.38K		-2.4M		-169.69%-1.44M
Gain on sale of security	94.84%-123.71K	----	-5,848.90%-2.72M	---327.57K	----	---2.4M	----	-126.31%-45.77K	----	----
Special income (charges)	----	----	--0	----	----	----	----	---669.13K	----	----
-Gain on sale of property,plant,equipment	----	----	--0	----	----	----	----	---669.13K	----	----
Other non- operating income (expenses)	----	----	92.41%-54.81K	----	----	----	----	-2.17%-722.24K	----	----
Income before tax	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	80.76%-516.56K	67.46%-191.47K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-294.14%-2.68M	55.55%-588.36K
Income tax
Net income	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M	48.51%-681.65K
Net income continuous Operations	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M	48.51%-681.65K
Minority interest income
Net income attributable to the parent company	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M	48.51%-681.65K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M	48.51%-681.65K
Basic earnings per share	99.25%-0.01	99.70%-0.001	88.30%-0.42	97.30%-0.0254	96.37%-0.02	-31.68%-1.33	72.50%-0.33	-49.58%-3.59	-394.74%-0.94	52.97%-0.5502
Diluted earnings per share	99.25%-0.01	99.70%-0.001	88.30%-0.42	97.30%-0.0254	96.37%-0.02	-31.68%-1.33	72.50%-0.33	-49.58%-3.59	-394.74%-0.94	52.97%-0.5502
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall